Literature DB >> 9122224

Importance of acidic, proline/serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: generation of transdominant-negative mutants.

K C Chin1, G G Li, J P Ting.   

Abstract

The class II transactivator (CIITA) is a master transcription regulator of gene products involved in the exogenous antigen presentation pathway, including major histocompatibility complex (MHC) class II, invariant chain, and DM. An extensive analysis of the putative functional domains of CIITA is undertaken here to explore the action of CIITA. Antibodies to CIITA protein were produced to verify that these mutant proteins are expressed. Both acidic and proline/serine/threonine-rich domains are essential for class II MHC promoter activation. In addition, three guanine nucleotide-binding motifs are essential for CIITA activity. Of these mutants, two exhibited strong transdominant-negative functions. These two mutants provide a plausible approach to manipulate MHC class II expression and immune responses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9122224      PMCID: PMC20117          DOI: 10.1073/pnas.94.6.2501

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  57 in total

Review 1.  T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex.

Authors:  R H Schwartz
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

Review 2.  Regulation of MHC class II genes: lessons from a disease.

Authors:  B Mach; V Steimle; E Martinez-Soria; W Reith
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

3.  GTP-binding domain: three consensus sequence elements with distinct spacing.

Authors:  T E Dever; M J Glynias; W C Merrick
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

4.  Preparation of nucleotide-free elongation factor Tu and its stabilization by the antibiotic kirromycin.

Authors:  O Fasano; J B Crechet; A Parmeggiani
Journal:  Anal Biochem       Date:  1982-07-15       Impact factor: 3.365

5.  Identification of an interferon-gamma response region 5' of the human histocompatibility leukocyte antigen DR alpha chain gene which is active in human glioblastoma multiforme lines.

Authors:  P V Basta; P A Sherman; J P Ting
Journal:  J Immunol       Date:  1987-02-15       Impact factor: 5.422

6.  Mutant ras-encoded proteins with altered nucleotide binding exert dominant biological effects.

Authors:  I S Sigal; J B Gibbs; J S D'Alonzo; G L Temeles; B S Wolanski; S H Socher; E M Scolnick
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

7.  Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity.

Authors:  G F Bottazzo; R Pujol-Borrell; T Hanafusa; M Feldmann
Journal:  Lancet       Date:  1983-11-12       Impact factor: 79.321

8.  Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets.

Authors:  R S Accolla
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

9.  A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes.

Authors:  C de Préval; B Lisowska-Grospierre; M Loche; C Griscelli; B Mach
Journal:  Nature       Date:  1985 Nov 21-27       Impact factor: 49.962

10.  aIr-1, a newly found locus on mouse chromosome 16 encoding a trans-acting activator factor for MHC class II gene expression.

Authors:  R S Accolla; M Jotterand-Bellomo; L Scarpellino; A Maffei; G Carra; J Guardiola
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

View more
  26 in total

1.  Two distinct domains within CIITA mediate self-association: involvement of the GTP-binding and leucine-rich repeat domains.

Authors:  M W Linhoff; J A Harton; D E Cressman; B K Martin; J P Ting
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

2.  CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.

Authors:  K Masternak; A Muhlethaler-Mottet; J Villard; M Zufferey; V Steimle; W Reith
Journal:  Genes Dev       Date:  2000-05-01       Impact factor: 11.361

Review 3.  Class II transactivator: mastering the art of major histocompatibility complex expression.

Authors:  J A Harton; J P Ting
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

4.  Self-association of CIITA and its transactivation potential.

Authors:  T J Sisk; S Roys; C H Chang
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

5.  Downregulation of CIITA function by protein kinase a (PKA)-mediated phosphorylation: mechanism of prostaglandin E, cyclic AMP, and PKA inhibition of class II major histocompatibility complex expression in monocytic lines.

Authors:  G Li; J A Harton; X Zhu; J P Ting
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

6.  CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation.

Authors:  S B Hake; K Masternak; C Kammerbauer; C Janzen; W Reith; V Steimle
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

Review 7.  Novel mechanisms of class II major histocompatibility complex gene regulation.

Authors:  Michael Radosevich; Santa Jeremy Ono
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

8.  Isolation of a putative Candida albicans transcriptional regulator involved in pleiotropic drug resistance by functional complementation of a pdr1 pdr3 mutation in Saccharomyces cerevisiae.

Authors:  D Talibi; M Raymond
Journal:  J Bacteriol       Date:  1999-01       Impact factor: 3.490

9.  CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo.

Authors:  K L Wright; K C Chin; M Linhoff; C Skinner; J A Brown; J M Boss; G R Stark; J P Ting
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

10.  The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.

Authors:  J A Brown; E M Rogers; J M Boss
Journal:  Nucleic Acids Res       Date:  1998-09-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.